Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2012
04/18/2012EP2027154B1 Immunoglobulin constant region domains with enhanced stability
04/18/2012EP1499358B1 Ph-sensitive polymer
04/18/2012EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/18/2012CN102421482A Antibodies specifically directed to the soluble form of ctla-4
04/18/2012CN102421452A 多价佐剂展示 Multivalent adjuvant show
04/18/2012CN102421446A 含花楸提取物并含有硒和/或锌添加的免疫刺激组合物 Sorbus containing extracts and containing selenium and / or immunostimulatory composition of zinc added
04/18/2012CN102421445A 制造营养品组成物的方法以及可利用该方法制成的营养品 The method of manufacturing nutritional composition and the method can be made use of nutritional supplements
04/18/2012CN102421443A 作为细胞因子活性调节剂的硫酸化的透明质酸 As sulfated hyaluronic acid cytokine activity modifiers
04/18/2012CN102421435A 使用PKC-θ抑制剂的免疫性疾病的离体治疗 In vitro treatment using inhibitors of PKC-θ autoimmune diseases
04/18/2012CN102417544A 一种紫阳富硒绿茶含硒多糖及其制备方法和用途 One kind of Ziyang selenium enriched green tea polysaccharide and its preparation and use
04/18/2012CN102417528A 一种噻唑(嗪)烷酮环连接的双糖化合物及其制备方法和其在药物制剂中的应用 Disaccharide compounds and methods of a thiazole (triazine) oxazolidinone ring connection and its application in drug formulations
04/18/2012CN102417489A 一种盐酸司他斯汀晶型f及其制备方法 One kind hydrochloride polymorph f setastine its preparation method
04/18/2012CN102417480A Spirocyclic nitriles as protease inhibitors
04/18/2012CN102416177A 鸡新城疫-H<sub>9</sub>亚型禽流感二联双佐剂灭活疫苗及其制备方法 Newcastle -H <sub> 9 </ sub> and avian influenza subtype double adjuvant inactivated vaccine and its preparation method
04/18/2012CN102416163A 一种含有植物血球凝集素或植物血球凝集素亚型的组合物 Containing phytohemagglutinin or phytohemagglutinin subtype composition
04/18/2012CN102416154A 一种沉香保健香囊 One kind of incense health Sachet
04/18/2012CN102416102A Refreshing and brain-invigorating tea
04/18/2012CN102416029A Ginseng submicron powder and preparation method and preparation thereof
04/18/2012CN102416017A 药用层孔菌中三种单体化合物的抗肿瘤活性及其在医药中的应用 Medicinal Phellinus anti-tumor activity of three monomer compound and its application in medicine
04/18/2012CN102416009A Transdermal granisetron
04/18/2012CN102415986A 含磷脂和胆盐的难溶性药物固体分散体及其制备方法 Phospholipid containing a poorly soluble drug and bile solids dispersion and its preparation method
04/18/2012CN102172358B 一种替米考星复方制剂及其制备方法和应用 One kind of tilmicosin compound and its preparation method and application
04/18/2012CN102048950B 一种滋补强壮保健酒及其制备方法 A strong health tonic wine and its preparation method
04/18/2012CN102000238B 九龙胶囊及制备方法 Kowloon capsule and preparation methods
04/18/2012CN101884726B Food therapy preparation for strengthening immunity based on theories of preventive treatment of disease and medicine food homology
04/18/2012CN101875920B DcR3和GAD65双基因共表达重组腺病毒及其制备方法和应用 DcR3 and GAD65 gene co-expression of recombinant adenovirus double its preparation method and application
04/18/2012CN101791315B 复方甘草酸单铵s药物组合物及其大容量注射剂制备方法 Glycyrrhizin monoammonium s pharmaceutical compositions and methods for preparing large-volume injection
04/18/2012CN101558810B 含牡丹叶的提高免疫力袋泡茶及其制作方法 Its production methods to improve immunity teabag containing peony leaves
04/18/2012CN101486975B Streptomycete, method for producing tacrolimus using the same and use thereof
04/18/2012CN101432000B 用于变应性眼病或变应性鼻病的包含三环性三唑并苯并氮杂*衍生物的预防剂或治疗剂 * Azepine derivative preventive or therapeutic agent for allergic ophthalmic diseases or allergic nasal diseases, comprising a tricyclic triazolo benzo
04/18/2012CN101411725B 一种提高免疫功能的海洋生物药 A way to improve immune function in marine biological drugs
04/18/2012CN101396365B 2-[六氢吡啶基]甲基-2,3-二氢咪唑[1,2-c]喹唑啉-5(6H)-酮的用途 2- [hexahydro-pyridyl] methyl-2,3-dihydro-imidazo [1,2-c] quinazolin--5 (6H) - one uses
04/18/2012CN101367834B 用于制备醇和酚的水溶性膦酰氧基甲基衍生物的方法 A water-soluble phosphine acyloxymethyl derivatives of alcohols and phenols used in the preparation of
04/18/2012CN101289477B 一种n-苯丙烯酰基壳寡糖及其制备 One kind n- benzene and preparation acryloyl Oligochitosan
04/18/2012CN101214345B 一种治疗湿疹皮炎、荨麻疹等各种瘙痒性皮肤病的中药制剂 A treatment for eczema, hives and other skin itching herbal preparations
04/17/2012US8158750 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
04/17/2012US8158621 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
04/17/2012US8158594 CYP1B1 nucleic acids and methods of use
04/17/2012US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy
04/17/2012US8158585 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
04/17/2012US8158418 Chimeric alphavirus replicon particles
04/17/2012US8158385 Cell death-inducing agent
04/17/2012US8158110 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
04/17/2012CA2585705C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
04/17/2012CA2543659C Useful immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs
04/17/2012CA2537044C Solid dispersions comprising tacrolimus
04/17/2012CA2493843C Azolidinone-vinyl fused-benzene derivatives
04/17/2012CA2445654C Anastomosis devices and methods for treating anastomotic sites
04/17/2012CA2431600C Molecules with extended half-lives, compositions and uses thereof
04/17/2012CA2402894C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method
04/17/2012CA2372181C Adjuvant combination formulations
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/12/2012WO2012048190A1 Annexin ii compositions and methods
04/12/2012WO2012048099A2 Nanoparticle-loaded cells
04/12/2012WO2012048093A2 Enhanced msc preparations
04/12/2012WO2012047989A1 Tnf inhibitor formulation for use in implantable infusion devices
04/12/2012WO2012047848A2 Allergen deactivator composition, articles and methods
04/12/2012WO2012047265A2 Improved adjuvant system for vaccine administration
04/12/2012WO2012047017A2 2,3-dihydro-isoindol-1-one derivative and a composition comprising the same
04/12/2012WO2012046793A1 Novel jak3 inhibitor containing, as active ingredient, thiophene derivative having ureido group and aminocarbonyl group as substituents
04/12/2012WO2012046001A1 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor
04/12/2012WO2012045801A1 Lactoferrin based complex coacervates and their uses
04/12/2012WO2012045157A1 Arih2 regulates dendritic cell activation and autoimmunity
04/12/2012WO2012045150A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
04/12/2012WO2012011113A3 Regulatory immune cells with enhanced targeted cell death effect
04/12/2012WO2012006083A3 Targeted receptor-mediated sirna
04/12/2012WO2012001093A3 Liquid formulations of rupatadine fumarate
04/12/2012WO2011126882A9 Therapeutic peptides and their derivatives and therapeutic uses thereof
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120088827 Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088814 Methods of modulating an immune response to a viral infection
04/12/2012US20120088784 Substituted Aromatic Compounds and Pharmaceutical Uses thereof
04/12/2012US20120088783 Chroman derivatives
04/12/2012US20120088782 Lpa receptor antagonist
04/12/2012US20120088780 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/12/2012US20120088769 Salts of arylsulfonamide ccr3 antagonists
04/12/2012US20120088762 Compounds for enzyme inhibition
04/12/2012US20120088757 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088749 S1P Receptor Modulating Compounds and Use Thereof
04/12/2012US20120088738 Inhibitors of fatty acid amide hydrolase
04/12/2012US20120088726 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
04/12/2012US20120088720 Inhibitors of protein tyrosine phosphatases
04/12/2012US20120088264 Methods for determining efficacy of chemotherapeutic agents
04/12/2012US20120087984 Stabilization of chemical compounds using nanoparticulate formulations
04/12/2012US20120087976 Adjuvant compositions comprising a non-ionic isotonicity agent
04/12/2012US20120087947 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
04/12/2012US20120087946 Recombinant bacterium and methods of antigen and nucleic acid delivery
04/12/2012US20120087945 Method for keeping an immunogenic composition available for administration to an animal
04/12/2012US20120087944 Oral vaccine fast-dissolving dosage form using starch
04/12/2012US20120087939 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
04/12/2012US20120087937 Novel compositions
04/12/2012US20120087936 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
04/12/2012US20120087935 Serine rich peptides having antioxidative stress properties
04/12/2012US20120087934 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
04/12/2012US20120087933 Enhanced msc preparations
04/12/2012US20120087932 Diagnostic test for virus
04/12/2012US20120087930 Marker of Streptococcus Anginosus/ Streptococcus Constellatus (MOAC) and Uses Thereof
04/12/2012US20120087925 Method for the treatment of inflammatory disorders